Clinical Edge Journal Scan

Clinical Edge Journal Scan

Similar outcomes of CAR-T cell therapy for nodal and extra nodal DLBCL

Publish date: April 17, 2023

• Read More

Clinical Edge Journal Scan

Dose-adjusted EPOCH and rituximab beneficial for selected older patients with high-risk DLBCL

Publish date: April 17, 2023

• Read More

Clinical Edge Journal Scan

Axi-cel a promising second-line treatment option for older patients with relapsed or refractory LBCL

Publish date: April 17, 2023

• Read More

Clinical Edge Journal Scan

Lenalidomide+rituximab+venetoclax a potential therapy option for untreated MCL

Publish date: April 17, 2023

• Read More

Clinical Edge Journal Scan

Higher rates of hospitalization, blood disorders, and infections among patients with MCL

Publish date: April 17, 2023

• Read More

Clinical Edge Journal Scan

Ibrutinib+BR a promising treatment option for newly diagnosed MCL ineligible for intensive therapy

Publish date: April 17, 2023

• Read More

Clinical Edge Journal Scan

Real-world data support the continued use of second-line targeted therapies in CLL

Publish date: April 17, 2023

• Read More

Clinical Edge Journal Scan

Commentary: Updates on the Treatment of Mantle Cell Lymphoma, April 2023

Publish date: March 30, 2023

• Read More

Clinical Edge Journal Scan

Standard first‐line chemotherapies for indolent B‐cell lymphoma impose varying risks for a second cancer

Publish date: March 23, 2023

• Read More

Clinical Edge Journal Scan

High-dose total body irradiation followed by stem cell transplantation offers long-term survival in MCL

Publish date: March 23, 2023

• Read More

Pages

• « first
• …
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• last »